![Michael Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Lee
Director/Board Member at
FATE THERAPEUTICS, INC.
Net worth: 27 761 $ as of 30/07/2026
Profile
Michael Stewart Lee is the founder of Redmile Group LLC, founded in 2007, where the title held is Managing Director.
Current jobs include Independent Director at Fate Therapeutics, Inc. since 2018 and Director at Gilda's Club New York City, Inc. Former jobs include Independent Director at Shattuck Labs, Inc. from 2020 to 2025, Director at AgomAb Therapeutics NV, Independent Director at IGM Biosciences, Inc. from 2019 to 2025, and Research Analyst at Welch Capital Partners LLC.
Education includes undergraduate studies at the University of Arizona.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 11/06/2026 | 11,331 ( 0.01% ) | 27 761 $ | 30/07/2026 | |
SHATTUCK LABS, INC. -.--% | 13/07/2025 | 0 ( -.--% ) | - $ | 30/07/2026 |
Michael Lee active positions
| Companies | Position | Start |
|---|---|---|
| FATE THERAPEUTICS, INC. | Director/Board Member | 30/07/2018 |
Redmile Group LLC
 Redmile Group LLC Investment ManagersFinance Redmile focuses primarily on making investments in US and non-US healthcare companies. They may also invest in fields related to healthcare where due diligence shows those healthcare assets are the driving force behind value creation and in other sectors from time to time. The firm uses fundamental research as part of their investment process. Their protocols include company financial models, market models, investment theses, and regular dialogue. Redmile’s sources include contacts with physicians, focus outside US, dialogue with companies, attendance at medical conferences; meetings with private companies, and regular dialogue within the team. | Founder | 28/02/2007 |
Gilda's Club New York City, Inc.
 Gilda's Club New York City, Inc. Miscellaneous Commercial ServicesCommercial Services Provides support services to cancer patients | Director/Board Member | - |
Former positions of Michael Lee
| Companies | Position | End |
|---|---|---|
| SHATTUCK LABS, INC. | Director/Board Member | 24/08/2025 |
| IGM BIOSCIENCES, INC. | Director/Board Member | 13/08/2025 |
Welch Capital Partners LLC
 Welch Capital Partners LLC Investment ManagersFinance WCP focuses on market leading, undervalued growth companies, seeking to buy above average growth at an attractive relative price. The firm utilizes rigorous fundamental, bottom-up research methods to understand the quality of the management team, including their investment process and ability to create sustained above market returns. | Analyst-Equity | 30/07/2006 |
| AGOMAB THERAPEUTICS NV | Director/Board Member | - |
Training of Michael Lee
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
64
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Welch Capital Partners LLC
Welch Capital Partners LLC Investment ManagersFinance WCP focuses on market leading, undervalued growth companies, seeking to buy above average growth at an attractive relative price. The firm utilizes rigorous fundamental, bottom-up research methods to understand the quality of the management team, including their investment process and ability to create sustained above market returns. | Finance |
University of Arizona
 University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Redmile Group LLC
Redmile Group LLC Investment ManagersFinance Redmile focuses primarily on making investments in US and non-US healthcare companies. They may also invest in fields related to healthcare where due diligence shows those healthcare assets are the driving force behind value creation and in other sectors from time to time. The firm uses fundamental research as part of their investment process. Their protocols include company financial models, market models, investment theses, and regular dialogue. Redmile’s sources include contacts with physicians, focus outside US, dialogue with companies, attendance at medical conferences; meetings with private companies, and regular dialogue within the team. | Finance |
Fate Therapeutics, Inc.
 Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Gilda's Club New York City, Inc.
Gilda's Club New York City, Inc. Miscellaneous Commercial ServicesCommercial Services Provides support services to cancer patients | Commercial Services |
Shattuck Labs, Inc.
 Shattuck Labs, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics for inflammatory and immune-mediated diseases | Health Technology |
IGM Biosciences, Inc.
 IGM Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops engineered IgM antibodies for the treatment of cancer patients | Health Technology |
AgomAb Therapeutics NV
 AgomAb Therapeutics NV BiotechnologyHealth Technology Develops molecular therapies for regeneration of damaged tissues | Health Technology |
- Stock Market
- Insiders
- Michael Lee
